Detalhe da pesquisa
1.
Antibody Persistence at 1 and 4 Years Following a Single Dose of MenAfriVac or Quadrivalent Polysaccharide Vaccine in Healthy Subjects Aged 2-29 Years.
Clin Infect Dis
; 61 Suppl 5: S521-30, 2015 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26553684